Antios Therapeutics has a total of 12 patents globally, out of which 1 has been granted. Of these 12 patents, all patents are active. Parallelly, United States of America seems to be the main focused R&D centre and also is the origin country of Antios Therapeutics.
Antios Therapeutics was founded in the year 2018. The Company operates as a biopharmaceutical company. The Company focuses on the development of novel antiviral therapies for unmet medical needs. Company serves customers worldwide.
Do read about some of the most popular patents of Antios Therapeutics which have been covered by us in this article and also you can find Antios Therapeutics patents information, the worldwide patent filing activity and its patent filing trend over the years, and many other stats over Antios Therapeutics patent portfolio.
How many patents does the founder and the CEO of Antios Therapeutics have?
The founder Abel De La Rosa has 4 patents, Douglas Mayers has 2 patents, Idean Marvasty has 0 patent and CEO Greg Mayes has 0 patent.
How many patents does Antios Therapeutics have?
Antios Therapeutics has a total of 12 patents globally. These patents belong to 5 unique patent families. Out of 12 patents, all patents are active.
How Many Patents did Antios Therapeutics File Every Year?
Are you wondering why there is a drop in patent filing for the last two years? It is because a patent application can take up to 18 months to get published. Certainly, it doesn’t suggest a decrease in the patent filing.
| Year of Patents Filing or Grant | Antios Therapeutics Applications Filed | Antios Therapeutics Patents Granted |
| 2022 | 5 | 1 |
| 2021 | 1 | – |
| 2020 | 3 | – |
| 2019 | 3 | – |
How many Antios Therapeutics patents are Alive/Dead?
All the Patents were filed by Antios Therapeutics are Alive.
How Many Patents did Antios Therapeutics File in Different Countries?
Countries in which Antios Therapeutics Filed Patents
| Country | Patents |
| Brazil | 2 |
| China | 2 |
| Europe | 2 |
| South Africa | 1 |
| United States Of America | 1 |
| Hong Kong (S.A.R.) | 1 |
Where are Research Centres of Antios Therapeutics Patents Located?
What Percentage of Antios Therapeutics US Patent Applications were Granted?
Antios Therapeutics (Excluding its subsidiaries) has filed 1 patent applications at USPTO so far (Excluding Design and PCT applications). Out of these 1 have been granted leading to a grant rate of 100.0%.
Below are the key stats of Antios Therapeutics patent prosecution at the USPTO.
Which Law Firms Filed Most US Patents for Antios Therapeutics?
| Law Firm | Total Applications | Success Rate |
| Taft Stettinius & Hollister | 1 | 100.00% |
List of Antios Therapeutics Patents
| Antios Therapeutics Patents | Title |
| US20230076319A1 | Inhibitors Of Hepatitis B Virus |
| EP3972979A1 | Oxalamido-Substituted Tricyclic Inhibitors Of Hepatitis B Virus |
| EP3833672A1 | Tricyclic Inhibitors Of Hepatitis B Virus |
| CN114555608A | Oxamide Substituted Hepatitis B Virus Tricyclic Inhibitors |
| CN113272309A | Tricyclic Inhibitors Of Hepatitis B Virus |
| WO2022256490A9 | Improved Synthesis Of Phosphoramidates For The Treatment Of Hepatitis B Virus |
| WO2022261046A1 | Compositions And Methods Of Treating Hepatitis D And Hepatitis B/Hepatitis D Co-Infections With Phosphoramidate Clevudine Prodrugs |
| WO2022251594A1 | Pharmacokinetics And Dose-Related Improvments In Subjects Treated With Phosphoramidate Clevudine Prodrugs |
| BR112021002565A8 | Compound, Pharmaceutically Acceptable Salt, Tautomer Or Stereoisomer Thereof, Pharmaceutical Composition, Process For Synthesis And Use Of Such Compound |
| BR112021023522A8 | Compound Or A Pharmaceutically Acceptable Salt, Tautomer, Solvate Or Stereoisomer Thereof, Pharmaceutical Composition, Process For Synthesis Of The Compound And Use Of The Compound |
| ZA202109005B | Oxalamido-Substituted Tricyclic Inhibitors Of Hepatitis B Virus |
| HK40068320A | Oxalamido-Substituted Tricyclic Inhibitors Of Hepatitis B Virus |
What are Antios Therapeutics key innovation segments?
What Technologies are Covered by Antios Therapeutics?
The chart below distributes patents filed by Antios Therapeutics